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he homologous mammalian rho kinases (ROCK I
and II) are assumed to be functionally redundant,
based largely on kinase construct overexpression.
As downstream effectors of Rho GTPases, their major
substrates are myosin light chain and myosin phos-
phatase. Both kinases are implicated in microﬁlament
bundle assembly and smooth muscle contractility. Here,
analysis of ﬁbroblast adhesion to ﬁbronectin revealed
that although ROCK II was more abundant, its activity
was always lower than ROCK I. Speciﬁc reduction of
ROCK I by siRNA resulted in loss of stress ﬁbers and fo-
cal adhesions, despite persistent ROCK II and guanine
T
 
triphosphate–bound RhoA. In contrast, the microﬁlament
cytoskeleton was enhanced by ROCK II down-regula-
tion. Phagocytic uptake of ﬁbronectin-coated beads was
strongly down-regulated in ROCK II–depleted cells but
not those lacking ROCK I. These effects originated in part
from distinct lipid-binding preferences of ROCK pleckstrin
homology domains. ROCK II bound phosphatidylinositol
3,4,5P
 
3
 
 and was sensitive to its levels, properties not
shared by ROCK I. Therefore, endogenous ROCKs are
distinctly regulated and in turn are involved with different
myosin compartments.
 
Introduction
 
Small Rho GTPases are molecular switches that control actin
cytoskeleton organization, cell adhesion and migration, gene
expression, microtubule dynamics, and vesicle transport
(Etienne-Manneville and Hall, 2002). Two homologous
serine/threonine kinases (ROCK I and II, also known as
ROK
 
 
 
 and 
 
 
 
, respectively) are major Rho effectors and are
implicated in the formation of stress fibers and focal adhe-
sions in nonmuscle cells, contractility of smooth muscle, and
suppression of neurite outgrowth (Riento and Ridley, 2003).
Both isoforms are composed of an NH
 
2
 
-terminal kinase do-
main, coiled-coil domain, Rho-binding domain, and pleck-
strin homology (PH) domain. Major ROCK substrates in the
regulation of actomyosin contraction are myosin light chain 2
(MLC2; Kureishi et al., 1997) and the myosin-binding sub-
unit of myosin phosphatase (MYPT; Kawano et al., 1999).
Rho kinases can also phosphorylate and activate LIM kinases,
which regulate an actin-depolymerizing protein, cofilin (Mae-
kawa et al., 1999). The central role of ROCKs in micro-
filament architecture is underscored by the inhibitor Y-27632,
which although not entirely specific for these kinases (Davies
et al., 2000; Narumiya et al., 2000) has been shown to block
or reverse bundle formation and contraction.
ROCK I and II have been assumed to perform the same
functions, but most studies have been accompanied by the
overexpression of kinase dead, constitutively active mutant or
wild-type forms of one isoform. Distinctions between the
ROCKs have been only rarely drawn; ROCK I but not ROCK
II, for instance, is sensitive to caspase 3–mediated cleavage in
apoptotic cells (Coleman et al., 2001; Sebbagh et al., 2001).
However, analysis of the ROCK II–deficient mouse suggested
that there is no compensation for the loss of ROCK II by
ROCK I (Thumkeo et al., 2003). Approximately 90% of null
embryos died in utero, accompanied by placental defects,
whereas those born were runted. Moreover, RhoE inhibits
ROCK I, but not ROCK II, with a loss of stress fibers (Riento
et al., 2003, 2005), indicating that ROCK II cannot compensate
for the decreased ROCK I activity. However, although the im-
portance of the rho kinases in many cellular processes is under-
stood, no clear dissection of roles for ROCK I and II has been
described. Here, we show distinct roles for ROCK I and II
in the same cells. We show that although ROCK I rather than II
is important for stress fiber formation, ROCK II acts as a
counterbalance in regulating the microfilament bundle and
focal adhesion site. ROCK II activity is involved in phagocyto-
sis of matrix-coated beads, a function not sensitive to ROCK I
depletion.
 
Correspondence to John R. Couchman: j.couchman@imperial.ac.uk
Abbreviations used in this paper: FN, fibronectin; GRP1, general receptor for
phosphoinositides-1; LPA, lysophosphatidic acid; MLC, myosin light chain;
MYPT, myosin-binding subunit of myosin phosphatase; PH, pleckstrin homology;
PI, phosphoinositide; PtdIns, phosphatidylinositol; REF, rat embryo fibroblast. 
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Results
 
ROCK I and II in fibroblast adhesion have 
different activity profiles
 
In response to seeding on fibronectin (FN) substrates, primary
rat embryo fibroblasts (REF) attached, spread, and formed fo-
cal adhesions over a 2–3 h period. Using a pull-down assay,
levels of GTP-RhoA peaked at around 2 h (Fig. 1 A), when
large, stable focal adhesions formed in agreement with other
studies (Ren et al., 1999). At all time points, GTP-RhoA could
be detected, including in rounded cells at 0 h. Rho kinase activ-
ity was measured in immunoprecipitates at the same time
points using antibodies monospecific for ROCK I or II (Fig. 1,
B–D) and recombinant GST-MLC chimeric protein as sub-
strate (Amano et al., 1996). There was no detectable alteration
of either ROCK protein expression level during cell–matrix ad-
hesion (Fig. 1 C). Three trends in activity could be observed.
First, ROCK I activity levels, normalized to protein mass, were
always higher than those of ROCK II (Fig. 1 D), although cells
contained approximately twice the protein levels of ROCK II
compared with ROCK I (unpublished data). Second, ROCK II
activity was low throughout the adhesion process, except for a
brief period 
 
 
 
30 min after seeding. Third, ROCK I activity, in
particular, could be detected at all time points, and like GTP-
RhoA levels, was quite substantial in rounded cells. Overall,
the data indicated that the adhesion process had a particular re-
quirement for ROCK I. As a further test, serum-starved REF
were treated with lysophosphatidic acid (LPA), known to ele-
vate GTP-RhoA levels in Swiss3T3 cells (Ridley and Hall,
1992). LPA treatment resulted in substantial elevation of GTP-
RhoA levels as expected (Fig. 2 A). This was matched by a
larger increase in ROCK I compared with ROCK II activities,
correlating temporally with stress fiber and focal adhesion for-
mation (Fig. 2 B).
The necessity for persistent ROCK activity throughout
the adhesion process was examined by treating fibroblasts with
the rho kinase inhibitor Y-27632 (Narumiya et al., 2000) at
times from seeding to 3 h. In all cases, microfilament bundles
dissipated, and any focal adhesions that formed at 1.5–3 h after
seeding, disassembled. This confirmed that rho kinase activity
was continuously required through the adhesion process and
that addition of Y-27632 at any time would disrupt the mi-
crofilament architecture.
 
ROCK I but not ROCK II activity is 
essential for focal adhesion and stress 
fiber formation
 
To establish whether ROCK I and II were separable in their
ability to regulate stress fibers and focal adhesions, siRNA
techniques were used to reduce levels of each specifically. As
an aid to identification of transfected cells, fluorochrome-
conjugated nucleotides were used. These experiments showed
a striking contrast in terms of cytoskeletal reorganization. De-
pletion of ROCK I in REF (Fig. 3 A) and Rat-1 cells (not de-
picted) led to almost complete loss of stress fibers and focal
adhesions, as monitored by F-actin and paxillin localizations.
Similar results were seen when distributions of vinculin,
 
 
 
-actinin, and phosphotyrosine were examined (unpublished
data). Residual focal complexes at the cell margins were
observed. Western blotting showed an 
 
 
 
70% reduction in
ROCK I protein in the cell population as a whole, but normal
levels of ROCK II (Fig. 3 B). Reduction in ROCK II had al-
most opposite effects, with stress fibers and focal adhesions
becoming exaggerated beyond that normally seen in these fi-
Figure 1. Activity profiles of ROCK I and II in fibroblast adhesion. (A) Serum-
starved REF were plated on FN-coated plates and lysates were prepared
at times up to 3 h. GTP-RhoA was pulled down with GST-Rhotekin–immobi-
lized beads. RhoA protein levels in total cell lysate and pull down samples
were calculated from Western blots and relative GTP-RhoA levels were
normalized to time 0. Error bars show SD. (B) ROCK I and II immunopre-
cipitates and total cell lysates were subjected to SDS-PAGE and Western
blotting with ROCK antibodies. Each antibody is monospecific and only
recognizes one ROCK protein. (C) ROCK I and II and actin protein levels
in cell lysate from REF plated on FN for the indicated times were analyzed
by Western blotting. No changes through cell adhesion were seen. (D)
ROCK I and II were specifically immunoprecipitated from lysates at the
indicated times in fibroblast adhesion on FN. Kinase activities in immuno-
precipitates were analyzed with GST-MLC as substrate. Background radio-
label levels from negative control precipitates were subtracted and the
data was normalized to ROCK protein levels in the immunoprecipitates.
Error bars show SD.
Figure 2. Rho kinase activity in relation to microfilament bundle formation.
(A and B) Serum-starved REF were stimulated with 400 ng/ml LPA or con-
trol buffer for 5 min and lysed. (A) GTP-RhoA was pulled down from cell
lysates and analyzed by Western blotting. One example from duplicate
experiments is shown, with increased levels of GTP-RhoA after LPA treat-
ment. (B) Each ROCK was specifically immunoprecipitated, and kinase
activities in immunoprecipitates were analyzed as described in Materials
and methods. Means of duplicates are shown. Whereas ROCK I activity
was enhanced by LPA treatment, that of ROCK II was little changed. 
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broblasts (Fig. 3, A and B). Characteristically, ROCK II–
depleted cells had an elongated and flattened morphology
with long trailing extensions. Focal adhesion components could
often be detected extending away from focal adhesions along
the stress fibers. As before, Western blotting showed that pro-
tein levels of the alternate rho kinase (ROCK I in this case)
were unchanged. ROCK II itself, however, was depleted by
 
 
 
70% across the cell population. In ROCK II siRNA-treated
cells, the prominent stress fibers and focal adhesions were
completely susceptible to Y-27632 treatment (Fig. 3 A) or
ROCK I siRNA oligonucleotides to accomplish double deple-
tion of both rho kinases (Fig. 3 A). The morphological char-
acteristics of double depleted cells were essentially additive.
Stress fibers and focal adhesions were completely absent, but
the extended flattened morphology of ROCK II–depleted
cells was observed also, rather than the more convex, rounded
cell margins of ROCK I–depleted cells. Phalloidin and vincu-
lin fluorescence were quantitated in transfected fibroblasts.
Both were significantly increased in ROCK II siRNA-trans-
fected cells (1.6- and 1.4-fold, respectively, P 
 
  
 
0.001 for
both F-actin and vinculin, 
 
n
 
 
 
  
 
27) compared with mock-
transfected controls (
 
n
 
   
 
15). Fluorescence levels in ROCK I
siRNA-treated cells were not significantly different to con-
trols, despite the distinctly different organization of F-actin
and vinculin.
Two conclusions can be drawn. First, the two rho kinases
have separable roles, with ROCK I being largely responsible
for stress fiber and focal adhesion formation. Second, ROCK II
was incapable of substituting for ROCK I in the latter’s ab-
sence. Control cells, transfected with an irrelevant siRNA oli-
gonucleotide, were unaffected in cell morphology and actin cy-
toskeleton. Vector-based siRNA experiments to deplete ROCK
II were not quite as successful (60% reduction in protein over-
all), but transfected cells acquired the same elongated pheno-
type with extensive microfilament bundles. In other control ex-
periments, fibroblasts were cotransfected with siRNA together
with full-length ROCK cDNA from a different mammalian
species (and therefore not susceptible to siRNA down-regula-
tion because of nucleotide differences) to show that the pheno-
types could be corrected (Fig. 3 C). Cells in these experiments
remained quite normal in morphology and actin cytoskeleton
characteristics. However, it should be noted that in these exper-
iments overexpression of either ROCK could restore a normal
phenotype in cells treated with either siRNA oligonucleotide.
Therefore, overexpression could obscure the specificity of the
two rho kinases, but also indicated that when present in excess
Figure 3. ROCK I but not ROCK II activity is essential for focal
adhesion and stress fiber formation. (A) Fibroblast cultures
were transfected with ROCK I, ROCK II, negative control, or
a mixture of ROCK I and II siRNA duplexes. After mainte-
nance culture for 2 d, cells were fixed and stained for paxillin
and F-actin. Arrowheads indicate transfected cells. 2 d after
transfection with siRNA duplexes, REF were incubated with
Y-27632 (10  M) in the presence of FCS. After 30 min, cells
were fixed and stained for F-actin. In all cases, stress fibers
were sensitive to Y-27632 addition. (B) Total cell lysates of
REF prepared 2 d after transfection with ROCK I (I), ROCK II
(II), or control (C) siRNA duplexes were analyzed by Western
blotting for ROCK I, ROCK II, and actin. In each case, total
populations were analyzed, containing some nontransfected
cells. Results from cultures where 80–90% of cells were trans-
fected are shown. (C) REF were cotransfected with myc-
tagged full-length human ROCK I or bovine ROCK II cDNA
and cy3-labeled ROCK I or II siRNA duplexes. 2 d after trans-
fection, cells were fixed and stained for myc and F-actin.
Either ROCK cDNA can restore a normal phenotype. Arrow-
heads indicate cotransfected cells. Bars, 50  m. 
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ROCK II could promote stress fiber formation. REF were also
seeded on serum, FN, or type I collagen-coated substrates, with
near identical outcomes from siRNA treatments. Therefore,
these effects were not related to a single integrin occupancy.
 
ROCK II activity facilitates phagocytosis
 
Another aspect of cell–matrix interactions was revealed by a
study of phagocytic uptake of FN-coated latex beads. In these
experiments, it was seen that ROCK II siRNA-treated cells
were significantly impaired in comparison to control cultures
or those depleted of ROCK I (Fig. 4 A and Table I). Laser
scanning microscopy showed that fibroblasts could readily in-
ternalize FN-coated 1-
 
 
 
m beads, but not if lacking ROCK II
(Fig. 4 B). To facilitate quantitation, cells were exposed to the
red fluorescing coated beads, fixed, and then treated with anti-
FN antibodies. Subsequent Alexa488 secondary antibody
treatment therefore only detected externalized, but not inter-
nalized, beads. Dual fluorochrome imaging readily discrimi-
nated bead populations.
 
Rho kinase distributions and depletion by 
siRNA treatment
 
In further experiments, to show the differences between ROCK
I and II, immunofluorescence microscopy revealed a distinct
distribution of each protein (Fig. 5). Whereas ROCK I was
mainly diffuse and perinuclear with some decoration of stress
fibers, ROCK II was present at cell margins as well as in in-
tensely staining of perinuclear locations. Specific siRNA treat-
ment showed the concomitant down-regulation of each rho ki-
nase as appropriate to the treatment. In many cases, staining
was close to background, indicating that the overall 70% reduc-
tion in protein levels reflected incomplete transfection of the
population (confirmed by microscopic analysis of cells for the
fluorochrome-conjugated siRNA oligonucleotides). In many
cases individual cells appeared to have almost total loss of the
appropriate protein. Levels and distribution of staining were
not markedly changed in the alternative kinase, consistent with
siRNA specificity (Fig. 5). ROCK I distribution was similar to
that reported previously (Riento et al., 2003).
 
Rho kinase–depleted cells are not 
deficient in GTP-bound RhoA
 
ROCK I–depleted cells that lacked stress fibers, as well as
ROCK II–depleted cells that possessed them but had reduced
phagocytic activity, contained similar levels of GTP-RhoA and
Rac1, only slightly lower than equivalent negative control
siRNA (Fig. 6 A). Moreover, ROCK I siRNA-treated fibro-
blasts could be cultured in the presence of serum, containing
LPA, yet stress fiber formation was not restored. This result
was consistent with the finding that ROCK I is substantially
more responsive to LPA treatment.
 
Effects of ROCK depletion on growth
 
The very large spread areas of ROCK II and double-depleted
cells suggested hypertrophy. This was confirmed in rounded
Figure 4. ROCK II–deficient fibroblasts have low phagocytic activity. REF
transfected with ROCK I (A), ROCK II (B), and control (C) siRNA were ana-
lyzed for phagocytic activity with FN-coated latex red beads as described
in Materials and methods. After a 1-h incubation with beads, the cells were
fixed and stained for extracellular FN. Three-dimensional fluorescence
images of FN (green) and latex beads (red) were recorded from laser scan-
ning confocal microscopy. Intracellular, phagocytosed beads could be seen
as red only, whereas beads remaining extracellularly could be detected in
both red and green channels. Quantitation is shown in Table I.
 
Table I. 
 
Fibroblast phagocytosis of FN-coated beads
 
n
 
Average of percentage 
of incorporated beads
 
ROCK I siRNA 20 37.2 
 
 
 
 5.1
 
a
 
ROCK II siRNA 22 18.3 
 
 
 
 3.6
Control siRNA 21 49.0 
 
 
 
 6.4
 
a
 
LY294002 15 18.9 
 
 
 
 3.3
 
b
 
DMSO (control for LY294002) 15 34.5 
 
 
 
 5.0
Blebbistatin 21 14.0 
 
 
 
 2.2
 
b
 
DMSO (control for Blebbistatin) 25 30.4 
 
 
 
 3.0
Y27632 19 19.0 
 
 
 
 2.9
 
c
 
Control (control for Y27632) 18 49.4 
 
 
 
 3.5
 
a
 
P 
 
 
 
 0.002, ROCK I siRNA versus ROCK II siRNA and control siRNA versus
ROCK II siRNA.
 
b
 
P 
 
 
 
 0.02.
 
c
 
P 
 
 
 
 0.001. 
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cells by morphometry. Cells depleted of ROCK II were 38%
larger in volume on average (Fig. 6 B). Cell cycle analysis
showed a small population (2–3%) of apoptotic cells in both
ROCK I– and II–depleted populations, against 
 
 
 
1% in con-
trols. However, growth was markedly retarded in treated cells
(Fig. 6 C), with increasing numbers of binucleate cells after
ROCK I siRNA treatment. This was consistent with a large
pool of cells having a DNA content equivalent to G2/M phase.
Extensive cell death from ROCK I siRNA treatment has been
reported, but this was not seen here (Chevrier et al., 2002). De-
spite the clear changes in microfilament organization, both
ROCK I– and II–depleted cells could be observed to round
up and spread in the course of time-lapse video microscopy
(unpublished data). Consistent with this data, treatment with
Y-27632 also strongly retarded REF cell growth in a dose-
dependent manner. Observations of treated cells indicated that
they could enter mitosis but not successfully complete it.
 
Both ROCKs can phosphorylate the 
same substrates
 
Examination of the two major substrates for rho kinases,
MLC2 (Kureishi et al., 1997) and MYPT (Kawano et al.,
1999), showed that both could be phosphorylated by ROCK I
and II in vitro (Fig. 1 D and Fig. 7 A). However, immunofluo-
rescence microscopy with phosphospecific antibodies showed
that phosphorylation of MLC2 on serine 19 was much reduced
in ROCK I–depleted cells, but not in those lacking ROCK II.
The large stress fibers in the latter cells were strongly deco-
rated with anti-phosphoMLC2 antibodies (Fig. 7 B). Correlat-
ing with fluorescence microscopy, marked depletion of MLC2
phosphorylation was also seen in ROCK I siRNA-treated cells
by Western blotting (Fig. 7 E). This was not seen in cells de-
pleted of ROCK II, where MLC2 phosphorylation was not sig-
nificantly different from mock-treated controls (Fig. 7 E). A
further Western blotting control experiment showed a near to-
Figure 5. Endogenous ROCK I and II have distinct distributions. (A) ROCK
I in REF cells is largely diffuse in the cytoplasm, more concentrated in peri-
nuclear regions, and sometimes associated with stress fibers (arrowhead). It
is not membrane associated unlike ROCK II (B; double arrowheads). ROCK
II is also intensely concentrated in perinuclear regions (B, D, and H). After
siRNA treatment to deplete ROCK I, its staining is correspondingly reduced
(C), whereas that of ROCK II is unaltered (D). Reciprocal results are seen
with ROCK II depletion (E and F). Control siRNA treatment was without
effect on either rho kinase staining pattern (G and H). Bars, 50  m.
Figure 6. ROCK I– and II–deficient cells contain normal GTPase profiles
but are growth retarded. (A) 2 d after siRNA duplex transfection, GTP-
RhoA and GTP-Rac1 were analyzed by pull-down assays. Levels are nor-
malized to negative control levels, and error bars indicate SD. In all cases,
levels were close to those of control cells. (B) 2 d after transfection with
siRNA duplexes, diameters of rounded cells were measured and volumes
were calculated as described in Materials and methods. Data were ana-
lyzed by one-way ANOVA and showed that cells depleted of ROCK II
were significantly larger than control, mock-transfected, or ROCK I–depleted
cells (P   0.001). Double depleted cells were similar to cells depleted of
ROCK II alone. (C) At the indicated days after transfection, cell numbers
were counted. Error bars show SD. In all cases, control transfections are
luciferase DNA target duplexes, whereas mock cultures received oligo-
fectamine only. 
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tal ablation of MLC2 phosphorylation on threonine 18 and
serine 19 after Y-27632 treatment (Fig. 7 C).
Two residues of MYPT, Thr696 and Thr853, are known
substrates for rho kinases (Hartshorne et al., 2004). Western
blotting with phosphospecific antibodies showed that both
were increased after single siRNA depletion of ROCK I but
not ROCK II (Fig. 7 F) when compared with controls. In
part, this resulted from 
 
 
 
45% reduction in MYPT protein
level in ROCK I–depleted cells. When both rho kinases were
inhibited by Y-27632 treatment, phosphorylation levels of
Thr853, but not Thr696, were reduced but not to background
(Fig. 7 D). In total, the data suggest that both rho kinases
contribute to MYPT phosphorylation in vivo, but the rela-
tionship is not simple because other kinases can phosphory-
late these residues (Hartshorne et al., 2004; Wilkinson et al.,
2005). The clearest correlation from these experiments was
between MLC2 phosphorylation, ROCK I activity, and stress
fiber formation.
Further analysis showed no changes in phosphorylation
levels of the LIM kinase substrate, cofilin, in response to siRNA
treatments. However, although LIM kinase 2 is suggested to be
a substrate for rho kinases in vivo (Sumi et al., 2001a), the same
residues in LIM kinase 2 are also phosphorylated by myotonic
dystrophy kinase-related Cdc42-binding kinase 
 
 
 
 (Sumi et al.,
2001b). LIM kinase 1 is downstream of p21-activated kinase
(PAK1; Edwards et al., 1999) and is not phosphorylated by full-
length ROCK I (Sumi et al., 2001a). Overall, because several
GTPases may lead to LIM kinase activation and cofilin phos-
phorylation, these results are not unexpected.
 
ROCK II PH domain can bind to inositol 
phospholipids
 
A comparison of the homology between the two rho kinases
shows that they have 92% identity in their kinase domains (Na-
kagawa et al., 1996), which is consistent with the ability to
phosphorylate the same substrates. ROCK I and II also have
closely similar rho-binding domains, although crystal struc-
tures of ROCK I with active RhoA and ROCK II alone are not
completely similar (Shimizu et al., 2003; Dvorsky et al., 2004).
There is no evidence currently that GTPases other than Rho
can activate these kinases in vivo. The PH domains of ROCK I
and II, on the other hand, have only 65–70% sequence identity
(Nakagawa et al., 1996; Leung et al., 1996), suggesting that
they may be a source of specificity. These were prepared as
cDNAs encoding GFP-conjugated fusion proteins and trans-
fected into cells to examine their subcellular localizations. Ap-
propriately sized proteins were detected in cell lysates by
Western blotting with ROCK antibodies (Fig. 8 A). At high ex-
pression levels in fibroblasts, both GFP-PH domain fusion pro-
teins inhibited microfilament bundle formation. However, in
low expressing cells, where such effects were not apparent, the
ROCK II PH domain had a preferential distribution in ruffling
membrane (P 
 
  
 
0.04), whereas that of ROCK I had a more
general cell membrane distribution (Fig. 8 B) and both rho ki-
nases PH domains could associate with microfilament bundles,
especially when cells were cultured in the absence of serum
(unpublished data). The ROCK II PH domain had a similar dis-
tribution to general receptor for phosphoinositides-1 (GRP1)-
PH-GFP, which binds to phosphatidylinositol (PtdIns) 3,4,5P
 
3
Figure 7. ROCKs can phosphorylate the same sub-
strates. (A) ROCK I and II immunoprecipitates from
REF were incubated with MBP-MYPT1 COOH-terminal
fragment and  -[
32P]ATP. Background radiolabel levels
from control immunoprecipitates have been deducted.
(B) 2 d after transfection with siRNA duplexes, cells
were fixed and stained for pMLC2 (Ser19) and F-actin.
ROCK I siRNA cells have depleted staining, whereas
the abundant stress fibers of ROCK II siRNA stain
strongly. Bar, 50  m. (C and D) Total cell lysates from
REF treated with Y-27632 in the presence of serum
were analyzed by Western blotting for MLC2 phos-
phorylation on Ser19 (p-MLC) or Thr18/Ser19 (pp-
MLC) (C) and MYPT phosphorylation on Thr853 or
Thr696 (D). Although MYPT phosphorylation on
Thr853 was reduced, more marked reductions were
seen in MLC2 phosphorylation after Rho kinase inhi-
bition. (E and F) Total cell lysates from cells trans-
fected with siRNA duplexes were analyzed by West-
ern blotting for MLC2 phosphorylation on Thr18/
Ser19 (E) and MYPT phosphorylation of Thr853 or
Thr696 (F). Phosphorylation is normalized to the rele-
vant protein level in the lysates. Phosphorylation levels
of MYPT were increased in the absence of ROCK I,
partly due to a decrease in myosin phosphatase pro-
tein levels in these cells. Error bars show SD. 
DIFFERENTIAL ROLES OF ROCK I AND II • YONEDA ET AL.
 
449
 
(Gray et al., 1999). Therefore, it seemed possible that the two
PH domains had different preferences for membrane lipids.
This has not been studied in any depth, though arachidonic acid
was reported to activate ROCK II from muscle (Feng et al.,
1999). Lipid binding assays revealed important differences be-
tween the two rho kinases (Fig. 8 C). ROCK I could not bind to
PtdIns 3,4,5P
 
3
 
, PtdIns3,4,P
 
2
 
, or PtdIns 4, 5P
 
2
 
. In contrast,
ROCK II strongly bound to PtdIns3,4,5P
 
3
 
 and PtdIns4,5P
 
2
 
,
consistent with its ruffling membrane distribution (Tall et al.,
2000; Insall and Weiner, 2001). Both rho kinases could bind to
PtdInsP isoforms. An identical assay with 
 
 
 
-actinin was per-
formed as a positive control (Fraley et al., 2003).
ROCK II could be expressed recombinantly and purified
from COS-7 cells. When purified under high salt conditions
(0.5 M), the kinase required the addition of RhoA-GTP
 
 
 
S for
activity, which could turn to be inhibited by Y-27632 (Fig.
8 D). Purification in physiological buffers resulted in con-
stitutively active kinase that was, nevertheless, inhibited by
Y-27632 (unpublished data). ROCK II purified under either con-
dition had increased activity when PtdIns3,4,5P
 
3
 
 or PtdIns4,5P
 
2
 
was added. No such increase was seen with PtdIns (Fig. 8 D).
Therefore, ROCK II can at least be partially activated, even in
the absence of RhoA-GTP, by two inositol phospholipids.
 
ROCK II activity is regulated by 
phosphoinositide (PI)-3 kinase activity
 
Confirmation of the relevance of this lipid binding was ob-
tained by further experiments with fibroblasts. First, in the
presence of the PI-3 kinase inhibitor LY294002 (Vlahos et al.,
1994), membrane association of the GFP-PH domain of ROCK
II was reduced, in contrast to the ROCK I equivalent that was
still membrane associated (Fig. 8 B). PI-3 kinase inhibition
also correlated with reduced ruffling membrane and was con-
sistent with a loss of GRP-1-PH from the membrane (Fig. 8 B).
Second, the presence of LY294002 markedly depressed ROCK
II activity, but had less effect on that of ROCK I in rounded
cells (Fig. 9 A). Further evidence that ROCK II activity segre-
gates with that of PI-3 kinase was obtained from phagocytic as-
says. Treatment of fibroblasts with LY294002 significantly
reduced FN-coated bead uptake, as had ROCK II siRNA
Figure 8. ROCK I and II PH domains do not
bind the same PIs. (A) COS7 cells were trans-
fected with ROCK I- or ROCK II-PH-GFP
cDNA. After 24 h of transfection, total cell
lysates were analyzed by Western blotting
with ROCK antibodies. Asterisks show endog-
enous ROCK proteins and arrowheads indi-
cate ROCK-PH-GFP proteins. (B) Fibroblasts
were transfected with ROCK I- or ROCK II-PH-
GFP or GRP1-PH-GFP cDNA. 1 d after trans-
fection, cells were fixed and stained for F-actin.
In other cases, transfectants were incubated
with 30  M LY294002 for 60 min in the pres-
ence of serum and fixed. Arrowheads indicate
cell margins with ruffles prominently contain-
ing ROCK II and GRP1-PH domains. These
structures are absent after PI-3 kinase inhibi-
tion. Bar, 50  m. (C) GST-ROCK I-PH, GST-
ROCK II-PH (3.3 nM), and  -actinin (10 nM)
were incubated with phospholipid-loaded
nitrocellulose membranes. Bound proteins
were detected with ROCK or  -actinin anti-
bodies as appropriate. Shown underneath
each blot are calibrations where known
amounts of each protein were spotted onto
nitrocellulose membranes and probed similarly
with antibodies. Different binding profiles of
ROCK I and II are evident. (D) Recombinant
myc-tagged ROCK II was purified from COS-7
cells (high salt method) and the kinase activity
was analyzed in the presence of GTP S GST-
RhoA (1  M), PIs (100  M), or Y-27632 (1
 M). Error bars show SD. 
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treatment (Fig. 9 and Table I). The sensitivity of this process to
rho kinase and myosin II inhibitors was confirmed by treatment
with Y-27632 and blebbistatin, respectively (Table I). It was
also seen that stress fibers dissipated as a result of blebbistatin
treatment, confirmation that this process also required myosin
II as previously reported (Limouze et al., 2004). In addition,
transient transfection with cDNA encoding the p110
 
 
 
 subunit
of PI-3 kinase led to corresponding protein expression and lo-
calization in membrane ruffles along with ROCK II but not
ROCK I. ROCK II activity in these cells was increased,
whereas that of ROCK I was unchanged (Fig. 9, B and C).
 
Discussion
 
Rho kinases are widespread and evolutionarily conserved
downstream effectors of Rho GTPases: RhoA, B, and C are all
potential activators whereas RhoE may be inhibitory (Riento et
al., 2003). They are central regulators of the microfilament cy-
toskeleton, phosphorylating both MLC2 and MYPT. ROCK I
and II are highly homologous in all domains except for their
PH domains and phosphorylate the same substrates. Both are
inhibited by Y-27632 (Narumiya et al., 2000), a compound that
depletes microfilament bundles and focal adhesions in a range
of cell types. However, the specificity of ROCK I and II in the
regulation of cytoskeletal organization has not been previously
recognized. This may be largely due to the fact that many ex-
periments on ROCKs have used overexpression, either of wild-
type, kinase dead, or constituent domains. Here, levels of one
kinase have been reduced, whereas levels of the other remained
unaltered. A key element of the current study is that the pres-
ence of GTP-RhoA and rho kinase does not directly corre-
late with kinase activity. The data is consistent with a further
regulatory step involving PH domain interactions. ROCK
I–depleted cells, for example, fail to assemble stress fibers and
focal adhesions despite the continued availability of ROCK II
and GTP-RhoA. The importance of ROCK PH domains is un-
derscored by the observation that high transient expression of
the ROCK I or II PH domains leads to disassembly of microfil-
ament bundles. Others have similarly shown the dominant-neg-
ative properties of these domains (Chen et al., 2002). Previous
work suggested PtdIns4,5P
 
2
 
 as an activator of ROCK II (Feng
et al., 1999), and it is possible that an unbound PH domain may
engender kinase quiescence.
Several different experiments suggest that ROCK II may
be regulated by PI-3 kinase activity. Moreover, purified recom-
binant ROCK II was partially activated by PtdIns3,4,5P
 
3
 
 and
PtdIns4,5P
 
2
 
. Further work is required to fully understand these
properties in vivo. For example, a recent paper suggests that
ROCK PH domains may also bind myosin heavy chain directly
(Kawabata et al., 2004). Once again, though, overexpression
would likely mask specificity. The current experiments have
revealed a major role for endogenous ROCK I in stress fiber
and focal adhesion formation. ROCK II’s role in these pro-
cesses is dispensable, and it may even dampen this response
because in its absence stress fiber formation is enhanced. This
was confirmed by quantification of F-actin and vinculin. In
contrast, phagocytosis of FN-coated beads, a process requiring
PI-3 kinase and myosin ATPase activities, is apparently depen-
dent on ROCK II rather than ROCK I. It is interesting that they
appear to regulate different aspects of cell–matrix interactions
involving myosin II. PI-3 kinase activity has previously been
implicated in phagocytosis and macropinocytosis (Cox et al.,
2002; Araki et al., 2003; Swanson and Hoppe, 2004). Phagocy-
tosis mediated by the complement receptor 3 pathway has been
shown to require rho kinase activity and myosin II for the en-
gulfment step (Olazabal et al., 2002). Phagocytosis may take
several forms, but our evidence suggests that one ROCK iso-
form can regulate an integrin-mediated internalization of ma-
trix-coated beads.
Although it may seem surprising that the two rho kinases
have specific roles, our data is consistent with some recent
findings. First, ROCK I is unable to compensate for the loss of
ROCK II in knock-out mice. However, trophoblasts from such
mice establish stress fibers in culture (Thumkeo et al., 2003).
Second, RhoE can bind ROCK I, but not II, and inhibit its func-
tion, with a resultant loss of stress fibers (Riento et al., 2003,
2005). Last, in work reported since this study was completed,
primary keratinocytes from ROCK I knock-out mice fail to es-
tablish stress fibers in response to epidermal growth factor
(Shimizu et al., 2005), although ROCK II levels were un-
changed. All these results are consistent with the hypothesis
presented here that ROCK I has a major role in stress fiber for-
mation and that the two rho kinases do not compensate for each
other, except when overexpressed.
The two endogenous kinases also have distinct distri-
butions in fibroblasts. ROCK I was diffusely, and widely dis-
tributed, sometimes associated with stress fibers, and more
concentrated in perinuclear regions. This has been noted
Figure 9. ROCK II activity is regulated by PI-3 kinase. (A) Serum-starved
REF were trypsinized and incubated with 10  M LY294002 or DMSO for
30 min at 37 C. ROCK immunoprecipitates were incubated with MBP-
MYPT1 COOH-terminal fragment and  -[
32P]ATP. Background radiolabel
levels from control immunoprecipitates have been deducted. ROCK activities
from REF treated with DMSO was indicated as one. (B) REF was cotrans-
fected with p110  and pEGFP-N1. 1 d after transfection, cells were fixed
and stained for ROCK I or II. Double arrowheads indicate transfected cells
and the single arrowhead shows the localization of ROCK II in membrane
ruffles. (C) ROCK immunoprecipitates from REF transfected with p110  or
control vector were incubated with GST-MLC and  -[
32P]ATP, and the
ROCK activities were measured. Activity of mock transfections is indicated
as one. Bar, 10  m. 
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previously (Riento et al., 2003). Cell membrane staining, par-
ticularly of ruffles was characteristic of ROCK II, but also ac-
companied by intense and more concentrated perinuclear dis-
tributions. These results are consistent with data showing a
GTP-RhoA dependent membrane association of ROCK II (Sin
et al., 1998).
Distinctions between ROCK I and II PH domains have
not been studied previously. They have 65% identical se-
quences, but also have differences in proline-containing re-
gions that may result in distinct tertiary structures. Chen et al.
(2002) have suggested a regulatory role for ROCK II PH do-
main, based on injection of domain-specific antibodies into
HeLa cells. It was noted, however, that such treatment had a
mild effect on actin and focal adhesions. It is also interesting
that neither PH domain binds LPA although a previous report
showed that LPA, phosphatidylserine, and PI can activate
ROCK II (Feng et al., 1999). Possibly, there are other binding
sites in ROCK II for negatively charged lipids. One feature in
common between ROCK I and II depletion was a lack of pro-
liferation, yet little apoptosis. This and the appearance of binu-
cleate cells are commensurate with previous papers suggesting
that ROCK I is required for cytokinesis (Chevrier et al., 2002).
However, a feature of ROCK II depletion was cellular hyper-
trophy. Moreover, it can be concluded that this was not due to
ROCK I activity in these cells because hypertrophy was also
seen in double-depleted cells. This recalls previous work show-
ing that ROCK II can antagonize insulin signaling through an
association with, and serine phosphorylation of, insulin recep-
tor substrate-1 (Begum et al., 2002). Also, cells derived from
p190-B Rho GTPase-activating protein–deficient mice had re-
duced size though insulin signaling was not inhibited (Sordella
et al., 2002). Because ROCK activity was high in these cells,
our results showing that deletion of ROCK II resulted in in-
creased cell size are entirely consistent. Furthermore, our data
also suggest that the intersection of ROCKs with insulin recep-
tor signaling may be specific for ROCK II and not shared with
ROCK I.
 
Materials and methods
 
Antibodies
 
Anti-Myosin (Light Chains 20K; MY-21), monoclonal anti-myc (9E10), and
polyclonal 
 
 
 
-actinin antibodies were purchased from Sigma-Aldrich. Poly-
clonal antibodies against ROCK I (K-18 and H-85), ROCK II (C-20 and
H-85), RhoA (119), MYPT1 (E-19), pMYPT1 (Thr853), pMYPT1 (Thr696),
and actin were obtained from Santa Cruz Biotechnology, Inc. Monoclonal
anti-paxillin antibody (Z035) was purchased from Zymed Laboratories.
Polyclonal antibodies against phospho-MLC2 (Thr18/Ser19) and phos-
pho-MLC2 (Ser19) were purchased from Cell Signaling Technology.
 
Plasmids
 
pGEX-2T-rhotekin RB and GST-PAK CRIB construct were gifts from A. Hall
(University College London, London, UK), pCAG-myc-p160ROCK(WT)
from S. Narumiya (Kyoto University, Kyoto, Japan), wild-type ROCK II
(pEF-BOS-myc-Rho kinase (p164)) and pGEX-2T-MLC wild type from K.
Kaibuchi (Nagoya University, Nagoya, Japan), and pcDNA3.1-p110
 
 
 
from J. Domin (Imperial College London, London, UK). The pMAL-MYPT1
(aa 714–1004) construct was purchased from the University of Dundee
(Velasco et al., 2002). Rat ROCK II cDNA was amplified by PCR from a
REF cDNA library. Complementary DNAs coding for human ROCK I PH
domain (aa 1113–1354) and rat ROCK II PH domain (aa 1145–1388)
were amplified by PCR and subcloned into the EcoRI–BamHI site of pGEX-
3X (GE Healthcare) and the KpnI–SmaI or BamHI–EcoRI sites of pEGFP-N1
(BD Biosciences). Human GRP1-PH cDNA was obtained from A. Magee
(Imperial College London, London, UK) and cDNA was subcloned into the
BamHI–EcoRI site of pEGFP-N1. All constructs were confirmed by DNA
sequencing.
 
Cell adhesion and pull-down assay
15-cm cell culture dishes (Corning Costar) were coated with 10  g/ml FN
(Sigma-Aldrich) overnight at RT. Coated dishes were blocked with 1 mg/
ml of heat-denatured BSA in PBS for 1 h at RT and washed three times with
PBS. REF cells were maintained in  -MEM (Invitrogen) containing 5% FCS
(Labtech International). 80% confluent REF cells were incubated overnight
with serum-free  -MEM. REF were trypsinized, resuspended in  -MEM con-
taining 0.25 mg/ml soybean trypsin inhibitor and 0.1 mg/ml BSA, and
collected. After removal of trypsin inhibitor, REF were suspended in
 -MEM containing 0.1 mg/ml BSA and kept in suspension for 30 min at
37 C. The cells were plated on FN-coated dishes and lysed at the various
time points. Pull-down assays for GTP-loaded RhoA and Rac1 were per-
formed according to Ren et al. (1999). The signals from Western blotting
were analyzed by National Institutes of Health image version 1.61.
Rho kinase assay
REF cells were lysed in 50 mM Tris-Cl, pH 7.4, 150 mM NaCl, 5% glyc-
erol, 1% Triton X-100, 10 mM MgCl2, 1 mM EGTA, 1 mM DTT, 25 mM
NaF, 20 mM  -glycerophosphate, 1 mM Na3VO4, complete protease in-
hibitor cocktail (Roche), and 5  g/ml pepstatin (buffer A). The lysates
were precleared by incubation with Ezview Red Protein G Affinity Gel
(Sigma-Aldrich) for 15 min at 4 C. Each ROCK isoform was specifically
immunoprecipitated from these lysates using goat polyclonal antibodies
coupled to protein G beads for 30 min at 4 C. After washing with buffer
A three times and with phosphorylation buffer (40 mM Tris-Cl, pH 7.4,
0.1% CHAPS, 10 mM MgCl2, 1 mM DTT, 1 mM EDTA, 1 mM EGTA,
phosphatase inhibitor cocktail [Sigma-Aldrich], 10 mM NaF, 10 mM
 -glycerophosphate, 1 mM Na3VO4, EDTA free protease inhibitor cocktail
[Roche], and 5  g/ml pepstatin) once, immunoprecipitates in the same
buffer were incubated with 4  g GST-MLC or maltose binding protein
(MBP)-MYPT1 (714–1004) and  -[
32P]ATP (3  Ci, 0.11 TBq/mmol, 74
MBq/ml, 20  M final concentration; GE Healthcare) at 30 C for 10 min.
The supernatants from the reactions were adsorbed onto P81 phosphocel-
lulose (Whatman). The membranes were washed with 1% H3PO4 four
times for 10 min, and membrane-bound radiolabel was measured by scin-
tillation counting. In a preliminary series of experiments, rho kinase activ-
ity was measured in lysates that had been allowed to stand at 4 C for
times up to 60 min. These experiments showed that activity persisted
through the period of preclearing and immunoprecipitation. A slow de-
cline in activity was noted so that the method adopted here was commen-
surate with the time required for specific purification of each kinase, with
minimal loss of activity. In some experiments, trypsinized REF were sus-
pended in  -MEM containing 0.1 mg/ml BSA and 10  M LY294002
(Merck Biosciences) or DMSO for 30 min at 37 C and then plated on FN-
coated plates. In other cases, serum-starved REF in a 15-cm dish were stim-
ulated with 400 ng/ml LPA (Sigma-Aldrich) for 5 min and then lysed for ki-
nase analysis.
To examine the ability of phospholipid to activate rho kinases, re-
combinant myc-ROCK I and ROCK II were transiently expressed in COS7
cells. 1 d after transfection, cells were lysed in buffer A lacking Triton X-100
and lysates were cleared by centrifugation. Recombinant proteins were
immunoprecipitated with anti–c-Myc-Agarose Affinity Gel (Sigma-Aldrich)
for 1 h at 4 C, and eluted with 100  g/ml of c-Myc peptide (Sigma-Aldrich)
in phosphorylation buffer containing 0.15 M or 0.5 M NaCl. Within 3 h
of purification, kinase assays were performed as described in the previous
paragraph with 3 ng of rho kinases, GST-MLC (4  g) in the presence of
1  M GTP S-GST-RhoA and/or 100  M phospholipid liposome, or 1  M
Y-27632. Liposomes composed of PtdIns, PtdIns4,5P2, or PtdIns3,4,5P3
(BIOMOL Research Laboratories, Inc.) were prepared as described previ-
ously (Couchman et al., 2002).
To calculate the ratio of ROCK I and II protein levels in REF, West-
ern blots and silver staining of immunoprecipitated proteins were quanti-
tated. Two different sets of ROCK I– and II–specific antibodies were used,
recognizing distinct domains of the kinases, with similar results. By cali-
brating the immunoprecipitates (using excess antibody) and relating the
same antibodies to Western blots, the protein levels could be compared.
Transfection and immunofluorescence microscopy
REF (10
4 cells) were cultured in 24-well plates on 13-mm-diam coverslips
overnight and transfected with ROCK PH-GFP or GRP1-PH-GFP plasmidsJCB • VOLUME 170 • NUMBER 3 • 2005 452
using Oligofectamine Transfection Reagent (Invitrogen) as described by
the manufacturer. 24 h after transfection, cells were fixed with 4% PFA in
PBS for 20 min and permeabilized with 0.1% Triton X-100 in PBS for 10
min. Double fluorescence microscopy was performed using the described
antibodies, followed by incubation with appropriate fluorochrome-conju-
gated secondary antibodies and phalloidin (Alexa Fluor 488/568/647;
Molecular Probes). For localization of ROCK I and II proteins, cells were
fixed with methanol/acetone (50:50) at  20 C for 5 min. Controls for
nonspecific cross-reacting of secondary antibodies were included and
gave no staining above background. Samples were analyzed on a Provis
AX module fluorescence microscope (Olympus; objectives: UPlanApo
40  1.0 oil iris, UPlanApo 60  1.4 oil; images were collected using a
SPOT Insight Mono digital camera) or on a confocal microscope (model
TCS NT; Leica; objective Fluorotar 100  1.4 oil PH3), and images were
processed using Adobe Photoshop 7.0. 24 h after transfection, 30  M
LY294002 or DMSO was added into transfectants in growth medium for
1 h. Cells were fixed and stained for F-actin. In some experiments, 10  M
Y-27632 (Merck Biosciences) was added to fibroblast culture seeded on
FN-coated plates for 30 min before the indicated times, and then cells
were fixed. Cells were stained for focal adhesion components, including
paxillin and F-actin. COS7 cells (3   10
4 cells) in 12-well plates were cul-
tured overnight in DME (Invitrogen) containing 10% FCS and transfected
with ROCK PH-GFP plasmids using Lipofectamine
 Transfection Reagent (In-
vitrogen) as described by the manufacturer. At 24 h after transfection,
cells were lysed with 1  Laemmli sample buffer and denatured. Samples
were subjected to SDS-PAGE and Western blotting with ROCK antibodies.
Silencing of ROCKs
Sense and antisense siRNA oligos corresponding to the target sequence for
rat ROCK I (AATCGGCAGAGGTGCATTTGG), for rat ROCK II (AACGTG-
GAAAGCCTGCTGGAT), and for luciferase as negative control (AACG-
TACGCGGAATACTTCGA) were synthesized by Ambion and annealed.
Uniqueness of individual target sequences was confirmed by a BLAST
search of rat and mouse databases. Duplex RNAs were labeled by Cy3
 or
FAM used by Silencer siRNA Labeling Kit (Ambion). Transfection of siRNA
(200 nM) was performed using Oligofectamine
 Reagent. Effective gene si-
lencing was observed at the 50-nM level. 24–72 h after transfection, cells
were analyzed. Cotransfection of Cy3-labeled siRNA duplexes with myc
full-length ROCK I or II plasmid were performed in control experiments and
cells were stained for myc-epitope and F-actin. Sense and anti-sense DNA
encoding a short hairpin RNA corresponding to the target sequence for rat
ROCK II, AAGTCGTGCTTGCACTGGATG, was cloned into the site of
BamHI and HindIII of pRNA-U6.1/Hygro vector (GenScript Corp.). REF
cells transfected stably with this construct or empty vector were selected in
growth medium containing hygromycin B (50  g/ml) for 2 wk. Single
clones were isolated and grown for cytoskeletal analysis.
Cell proliferation, cell cycle, and diameter analysis
REF cells were trypsinized at the indicated days after transfection with
siRNA duplex and were analyzed as described in the following sentences.
For cell proliferation assay, cell numbers were counted with a hemocytom-
eter. Cell cycle characteristics were analyzed with FACS (BD FACSCali-
bur; Cell Quest software) after staining with 25  g/ml propidium iodide
in PBS containing 0.1% Triton X-100 and 0.5 mg/ml RNase A. To ana-
lyze cell diameter, trypsinized cells were suspended in growth medium
and plated onto plastic dishes. At 2 min after plating, cells were fixed with
4% PFA and images were taken. Diameters of cells were measured with
Adobe Photoshop and cell volumes were calculated.
Protein lipid overlay assay
Human ROCK I PH domain and rat ROCK II PH domain were expressed in
Escherichia coli BL21 as GST fusion proteins and purified using glu-
tathione-agarose (Sigma-Aldrich) as described in Dowler et al. (2002) but
in the absence of detergent. Protein lipid overlay assay was performed on
PIP Strips (Echelon Biosciences) according to the methods of Dowler et al.
(2002). Binding was visualized with anti–ROCK I and II antibodies that
had been characterized and shown to react with the respective PH do-
mains.  -Actinin from chicken gizzard (Sigma-Aldrich) was used as a pos-
itive control.
Phagocytosis assays
Sulfate-modified latex red beads (average bead size 1.0  m; Sigma-
Aldrich) in 1 ml of a solution containing of 35 mM NaHCO3 and 15 mM
Na2CO3, pH 9.6, were coated with 30  g/ml of bovine FN (Sigma-
Aldrich) overnight at RT. After washing with PBS twice, coated beads
were blocked with 1% BSA in PBS for 2 h at RT. After further washing, FN-
coated beads were suspended in 1 ml PBS. Control beads were coated
with BSA alone. Fibroblast cultures were untreated or exposed to one of
30  M LY294002, 15  M ( ) blebbistatin (Merck Biosciences), 30  M
Y-27632, or DMSO as reference for LY294002 and blebbistatin in
 -MEM containing 5% FCS for 2 h (LY294002 and Y-27632 treatments)
or 0.5 h (blebbistatin treatment). Control or siRNA-transfected cells were
incubated at 4 C for 10 min and then  9   10
9 FN-coated beads were
added. Cells were further incubated at 4 C for 30 min to allow beads to
interact with the cell surface, and then incubated at 37 C for 1 h before
fixation with 4% PFA. Fixed cells were stained with anti-FN polyclonal an-
tibody followed by Alexa488 goat anti–rabbit IgG to detect FN-coated
beads remaining extracellularly. Three-dimensional fluorescence images
of FN (green) and latex beads (red) were recorded from laser scanning
confocal microscopy. Numbers of double-stained and total numbers of la-
tex beads were counted and percentages of phagocytosed beads were
compared by statistical analysis.
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